Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05096468
Other study ID # Z19110000661906703
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date December 1, 2021
Est. completion date October 15, 2022

Study information

Verified date July 2023
Source Beijing Tiantan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postsurgical pain is now known to be one of the most common and difficult-to-treat complications of surgery. severe postoperative pain can significantly impair patients' quality of life, social functioning and contribute to excessive health care expenditures. It is worth noting that acute postoperative pain may play a vital role in central sensitization and up-regulation of pain receptors, even factors implicated in the development of CPSP. According to previous studies, the incidence of postoperative pain among patients undergoing spinal surgery was nearly 80%. At the same time, perioperative pain management of patients undergoing spinal surgery has not been clearly. For the past few years, pregabalin and esketamine are becoming important roles in perioperative pain management, lots of studies have shown that these two analgesics might relieve postoperative pain. The aim of this study was to evaluate the acute analgesic effects of esketamine and pregabalin in combination after spinal cord neoplasms resection, so as to find a better way to help the patients undergoing spinal surgery keep away from the acute perioperative pain.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date October 15, 2022
Est. primary completion date June 28, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patient undergoing elective spinal cord neoplasms resection; - Ages between 18 and 65 years old; - American Society of Anaesthesiology (ASA) status I-III; - Signed informed consent. Exclusion Criteria: - Previous adverse reaction to ketamine, s-ketamine or pregabalin; - Patients with a diagnosed history of severe chronic pain; - Patients with long-term analgesic treatment(gabapentin/opioids/ketamine); - Patients with aphasia or inability to cooperate with the pain assessments; - Known sever insufficiency of vitals(such as heart failure/renal dysfunction/hepatic failure); - Patients with a diagnosed history of psychiatric disorder; - Patients treated with gabapentin/pregabalin in the last three months; - Drug abuse; - Body mass index (BMI) > 35 kg/m2 ; - Pregnancy or lactation.

Study Design


Intervention

Drug:
S-ketamine and pregabalin
Drug: Pregabalin 150mg (2hrs) pre operatively and 75mg twice daily post operatively for 7 days(POD1-7), followed by dose reduction to 75mg once daily for 7 days(POD8-14) Drug: S-ketamine infusion 0.5 mg/kg bolus after induction of anesthesia +0.12 mg/kg/h continuous intravenous infusion for 48 h
Normal saline and placebo capsule
Drug: Placebo capsules Two placebo capsules (2hrs) preoperatively and twice daily post operatively for 7days, followed by dose reduction to single capsule once daily for 7days Drug: Normal saline 0.9% saline bolus after induction of anesthesia + intravenous infusion for 48 hours

Locations

Country Name City State
China Beijing Tiantan Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Tiantan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the proportion of patients with acute moderate-to-severe postsurgical pain during 48h after operation The primary outcome was the proportion of patients with acute moderate-to-severe postsurgical pain during the 48-h postoperative period (defined as a VAS score = 40 mm). 48 hours after operation
See also
  Status Clinical Trial Phase
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT04167410 - Effect of Perioperative Glycemia Protocol on Glycemic Outcomes in Diabetic Patients Undergoing Abdominal Surgery N/A
Terminated NCT04506372 - Management of Angiotensin Inhibitors During the Perioperative Period N/A
Completed NCT04006106 - Defining ENDOtypes in Perioperative Hypersensitivity by Extensive Cellular and Molecular PHENotyping (ENDOPHEN)
Recruiting NCT06065137 - Standardised Drug Provocation Testing in Perioperative Hypersensitivity N/A
Completed NCT06203171 - Preoperative Evaluation on Perioperative Complications
Completed NCT04120324 - Incidence of 30 Day Return to Hospital Following Same Day Discharge Total Hip Arthroplasty
Not yet recruiting NCT06279000 - Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery Phase 3
Completed NCT02958293 - Perioperative Morbidity in Elective Surgery Based on the Time of the Year
Recruiting NCT04120012 - The Effect of Frailty to Perioperative Complications in the Elderly
Completed NCT04665349 - Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments N/A
Recruiting NCT04266574 - BRAIN-targeted Goal-directed Therapy in High-risk Patients undeRgOing Major electIve SurgEry: the BRAIN-PROMISE Study N/A
Recruiting NCT04256798 - Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery Phase 3
Completed NCT04260334 - Preoperative Care In Ovarian Cancer Patients N/A
Recruiting NCT05533112 - Binaural Beat Stimulation to Improve Patient Outcome After Surgery and Anesthesia N/A
Completed NCT06097052 - Hypotension Predictive Index Effect on Intraoperative Hypotension During Pancreatic Surgery.
Recruiting NCT06035627 - The Effect of Inadvertent Perioperative Hypothermia on Surgical Site Infection in Laparoscopic Choleistectomy.
Not yet recruiting NCT06326528 - SGLT2 Inhibitors and Perioperative Period
Recruiting NCT04347772 - Effectiveness of Intensive Perioperative Nutrition Therapy Among Adults Undergoing Gastrointestinal & Oncology Surgery N/A
Completed NCT03974321 - Intraoperative Hypotension and Perioperative Myocardial Injury